No Cover Image

Journal article 611 views

CYP56 (Dit2p) in Candida albicans: Characterization and Investigation of Its Role in Growth and Antifungal Drug Susceptibility / N. R Melo, G. P Moran, A. G. S Warrilow, E Dudley, S. N Smith, D. J Sullivan, D. C Lamb, Diane Kelly, D. C Coleman, S. L Kelly, Ed Dudley, Steven Kelly, Andrew Warrilow

Antimicrobial Agents and Chemotherapy, Volume: 52, Issue: 10, Pages: 3718 - 3724

Swansea University Authors: Diane Kelly, Ed Dudley, Steven Kelly, Andrew Warrilow

Full text not available from this repository: check for access using links below.

Check full text

DOI (Published version): 10.1128/AAC.00446-08

Published in: Antimicrobial Agents and Chemotherapy
ISSN: 0066-4804 1098-6596
Published: 2008
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa6349
Tags: Add Tag
No Tags, Be the first to tag this record!
first_indexed 2013-07-23T11:54:33Z
last_indexed 2018-02-09T04:33:03Z
id cronfa6349
recordtype SURis
fullrecord <?xml version="1.0"?><rfc1807><datestamp>2011-10-01T00:00:00.0000000</datestamp><bib-version>v2</bib-version><id>6349</id><entry>2011-10-01</entry><title>CYP56 (Dit2p) in Candida albicans: Characterization and Investigation of Its Role in Growth and Antifungal Drug Susceptibility</title><swanseaauthors><author><sid>5ccf81e5d5beedf32ef8d7c3d7ac6c8c</sid><firstname>Diane</firstname><surname>Kelly</surname><name>Diane Kelly</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>c7d05f992a817cd3b9a5f946bd909b71</sid><firstname>Ed</firstname><surname>Dudley</surname><name>Ed Dudley</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>b17cebaf09b4d737b9378a3581e3de93</sid><ORCID>0000-0001-7991-5040</ORCID><firstname>Steven</firstname><surname>Kelly</surname><name>Steven Kelly</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>f066e233e8d0136c9f547b86fa43747f</sid><ORCID>0000-0003-0183-8334</ORCID><firstname>Andrew</firstname><surname>Warrilow</surname><name>Andrew Warrilow</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2011-10-01</date><deptcode>PMSC</deptcode><abstract></abstract><type>Journal Article</type><journal>Antimicrobial Agents and Chemotherapy</journal><volume>52</volume><journalNumber>10</journalNumber><paginationStart>3718</paginationStart><paginationEnd>3724</paginationEnd><publisher/><placeOfPublication/><issnPrint>0066-4804</issnPrint><issnElectronic>1098-6596</issnElectronic><keywords/><publishedDay>31</publishedDay><publishedMonth>12</publishedMonth><publishedYear>2008</publishedYear><publishedDate>2008-12-31</publishedDate><doi>10.1128/AAC.00446-08</doi><url/><notes/><college>COLLEGE NANME</college><department>Medicine</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>PMSC</DepartmentCode><institution>Swansea University</institution><apcterm/><lastEdited>2011-10-01T00:00:00.0000000</lastEdited><Created>2011-10-01T00:00:00.0000000</Created><path><level id="1">Swansea University Medical School</level><level id="2">Medicine</level></path><authors><author><firstname>N. R</firstname><surname>Melo</surname><order>1</order></author><author><firstname>G. P</firstname><surname>Moran</surname><order>2</order></author><author><firstname>A. G. S</firstname><surname>Warrilow</surname><order>3</order></author><author><firstname>E</firstname><surname>Dudley</surname><order>4</order></author><author><firstname>S. N</firstname><surname>Smith</surname><order>5</order></author><author><firstname>D. J</firstname><surname>Sullivan</surname><order>6</order></author><author><firstname>D. C</firstname><surname>Lamb</surname><order>7</order></author><author><firstname>Diane</firstname><surname>Kelly</surname><order>8</order></author><author><firstname>D. C</firstname><surname>Coleman</surname><order>9</order></author><author><firstname>S. L</firstname><surname>Kelly</surname><order>10</order></author><author><firstname>Ed</firstname><surname>Dudley</surname><order>11</order></author><author><firstname>Steven</firstname><surname>Kelly</surname><orcid>0000-0001-7991-5040</orcid><order>12</order></author><author><firstname>Andrew</firstname><surname>Warrilow</surname><orcid>0000-0003-0183-8334</orcid><order>13</order></author></authors><documents/><OutputDurs/></rfc1807>
spelling 2011-10-01T00:00:00.0000000 v2 6349 2011-10-01 CYP56 (Dit2p) in Candida albicans: Characterization and Investigation of Its Role in Growth and Antifungal Drug Susceptibility 5ccf81e5d5beedf32ef8d7c3d7ac6c8c Diane Kelly Diane Kelly true false c7d05f992a817cd3b9a5f946bd909b71 Ed Dudley Ed Dudley true false b17cebaf09b4d737b9378a3581e3de93 0000-0001-7991-5040 Steven Kelly Steven Kelly true false f066e233e8d0136c9f547b86fa43747f 0000-0003-0183-8334 Andrew Warrilow Andrew Warrilow true false 2011-10-01 PMSC Journal Article Antimicrobial Agents and Chemotherapy 52 10 3718 3724 0066-4804 1098-6596 31 12 2008 2008-12-31 10.1128/AAC.00446-08 COLLEGE NANME Medicine COLLEGE CODE PMSC Swansea University 2011-10-01T00:00:00.0000000 2011-10-01T00:00:00.0000000 Swansea University Medical School Medicine N. R Melo 1 G. P Moran 2 A. G. S Warrilow 3 E Dudley 4 S. N Smith 5 D. J Sullivan 6 D. C Lamb 7 Diane Kelly 8 D. C Coleman 9 S. L Kelly 10 Ed Dudley 11 Steven Kelly 0000-0001-7991-5040 12 Andrew Warrilow 0000-0003-0183-8334 13
title CYP56 (Dit2p) in Candida albicans: Characterization and Investigation of Its Role in Growth and Antifungal Drug Susceptibility
spellingShingle CYP56 (Dit2p) in Candida albicans: Characterization and Investigation of Its Role in Growth and Antifungal Drug Susceptibility
Diane, Kelly
Ed, Dudley
Steven, Kelly
Andrew, Warrilow
title_short CYP56 (Dit2p) in Candida albicans: Characterization and Investigation of Its Role in Growth and Antifungal Drug Susceptibility
title_full CYP56 (Dit2p) in Candida albicans: Characterization and Investigation of Its Role in Growth and Antifungal Drug Susceptibility
title_fullStr CYP56 (Dit2p) in Candida albicans: Characterization and Investigation of Its Role in Growth and Antifungal Drug Susceptibility
title_full_unstemmed CYP56 (Dit2p) in Candida albicans: Characterization and Investigation of Its Role in Growth and Antifungal Drug Susceptibility
title_sort CYP56 (Dit2p) in Candida albicans: Characterization and Investigation of Its Role in Growth and Antifungal Drug Susceptibility
author_id_str_mv 5ccf81e5d5beedf32ef8d7c3d7ac6c8c
c7d05f992a817cd3b9a5f946bd909b71
b17cebaf09b4d737b9378a3581e3de93
f066e233e8d0136c9f547b86fa43747f
author_id_fullname_str_mv 5ccf81e5d5beedf32ef8d7c3d7ac6c8c_***_Diane, Kelly
c7d05f992a817cd3b9a5f946bd909b71_***_Ed, Dudley
b17cebaf09b4d737b9378a3581e3de93_***_Steven, Kelly
f066e233e8d0136c9f547b86fa43747f_***_Andrew, Warrilow
author Diane, Kelly
Ed, Dudley
Steven, Kelly
Andrew, Warrilow
author2 N. R Melo
G. P Moran
A. G. S Warrilow
E Dudley
S. N Smith
D. J Sullivan
D. C Lamb
Diane Kelly
D. C Coleman
S. L Kelly
Ed Dudley
Steven Kelly
Andrew Warrilow
format Journal article
container_title Antimicrobial Agents and Chemotherapy
container_volume 52
container_issue 10
container_start_page 3718
publishDate 2008
institution Swansea University
issn 0066-4804
1098-6596
doi_str_mv 10.1128/AAC.00446-08
college_str Swansea University Medical School
hierarchytype
hierarchy_top_id swanseauniversitymedicalschool
hierarchy_top_title Swansea University Medical School
hierarchy_parent_id swanseauniversitymedicalschool
hierarchy_parent_title Swansea University Medical School
department_str Medicine{{{_:::_}}}Swansea University Medical School{{{_:::_}}}Medicine
document_store_str 0
active_str 0
published_date 2008-12-31T03:18:03Z
_version_ 1714284483810689024
score 10.829733